SIMILAR RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT DURING LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS

被引：0

作者：

Papatheodoridis, George V. ^{[1
]}

Dalekos, George N. ^{[2
,3
]}

Yurdaydin, Cihan ^{[4
]}

Sypsa, Vana ^{[5
]}

van Boemmel, Florian ^{[6
]}

Buti, Maria ^{[7
,8
]}

Luis Calleja, Jose ^{[9
]}

Goulis, Ioannis ^{[10
]}

Manolakopoulos, Spilios ^{[1
,11
]}

Loglio, Alessandro ^{[12
]}

Papatheodoridi, Margarita ^{[1
]}

Gatselis, Nikolaos K. ^{[2
,3
]}

Keskin, Onur ^{[4
]}

Veelken, Rhea ^{[6
]}

Lopez Gomez, Marta ^{[13
]}

Hansen, Bettina E. ^{[14
,15
]}

Savvidou, Savvoula ^{[10
]}

Kourikou, Anastasia ^{[11
]}

Vlachogiannakos, Jiannis ^{[1
]}

Galanis, Kostas ^{[2
,3
]}

Idilman, Ramazan ^{[4
]}

Esteban-Mur, Rafael ^{[7
,8
]}

Janssen, Harry L. A. ^{[16
]}

Berg, Thomas ^{[17
]}

Lampertico, Pietro ^{[12
]}

机构：

[1] Univ Athens, Gen Hosp Athens Laiko, Sch Med, Dept Gastroenterol, Athens, Greece

[2] Thessalia Univ, Sch Med, Dept Internal Med, Volos, Greece

[3] Thessalia Univ, Sch Med, Res Lab, Volos, Greece

[4] Ankara Univ, Sch Med, Dept Gastroenterol, Ankara, Turkey

[5] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece

[6] Univ Clin Leipzig, Clin Gastroenterol & Rheumatol, Sect Hepatol, Leipzig, Germany

[7] Hosp Gen Univ Valle Hebron, Barcelona, Spain

[8] Ciberehd, Barcelona, Spain

[9] Univ Autonoma Madrid, Hosp Univ Puerta De Hierro Majadahonda, Liver Unit, Madrid, Spain

[10] Aristotle Univ Thessaloniki, Sch Med, Hippocrat Univ Hosp, Dept Internal Med 4, Thessaloniki, Greece

[11] Univ Athens, Gen Hosp Athens Hippokratio, Sch Med, Dept Internal Med 2, Athens, Greece

[12] Univ Milan, Fdn Irccs Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, CRC AM&A Migliavacca Ctr Liver Dis, Milan, Italy

[13] Hosp Univ Puerta De Hierro, Idiphim, Ciberehd, Madrid, Spain

[14] Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada

[15] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands

[16] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[17] Univ Hosp Leipzig, Sect Hepatol, Dept Gastroenterol & Rheumatol, Leipzig, Germany

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

454

引用

页码：286A / 287A

页数：2

共 50 条

[21] PAGE-B score is simpler and has similar predictive performance with the new Asian hepatocellular carcinoma risk scores in Caucasian chronic hepatitis B patients treated with long-term entecavir or tenofovir disoproxil fumarate therapy
Papatheodoridis, George
Dalekos, George
Idilman, Ramazan
Sypsa, Vana
van Boemmel, Florian
Buti, Maria
Calleja Panero, Jose Luis
Goulis, Ioannis
Manolakopoulos, Spilios
Loglio, Alessandro
Papatheodoridi, Margarita
Gatselis, Nikolaos
Veelken, Rhea
Lopez-Gomez, Marta
Hansen, Bettina
Savvidou, Savvoula
Kourikou, Anastasia
Vlachogiannakos, Ioannis
Galanis, Kostas
Yurdaydin, Cihan
Esteban, Rafael
Janssen, Harry
Berg, Thomas
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2020, 73 : S586 - S587
[22] Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Kim, W. Ray
Loomba, Rohit
Berg, Thomas
Schall, Raul E. Aguilar
Yee, Leland J.
Dinh, Phillip V.
Flaherty, John F.
Martins, Eduardo B.
Therneau, Terry M.
Jacobson, Ira
Fung, Scott
Gurel, Selim
Buti, Maria
Marcellin, Patrick
CANCER, 2015, 121 (20) : 3631 - 3638
[23] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
van Velsen, Lisa M.
Sonneveld, Milan J.
van Erpecum, Karel J.
HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922
[24] Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B
Lee, Hye Won
Kim, Seung Up
HEPATOMA RESEARCH, 2022, 8
[25] Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Liaw, Yun-Fan
Sheen, I-Shyan
Lee, Chuan-Mo
Akarca, Ulus Salih
Papatheodoridis, George V.
Wong, Florence Suet-Hing
Chang, Ting-Tsung
Horban, Andrzej
Wang, Chia
Kwan, Peter
Buti, Maria
Prieto, Martin
Berg, Thomas
Kitrinos, Kathryn
Peschell, Ken
Mondou, Elsa
Frederick, David
Rousseau, Franck
Schiff, Eugene R.
HEPATOLOGY, 2011, 53 (01) : 62 - 72
[26] Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B
Choi, Won-Mook
Choi, Jonggi
HEPATOMA RESEARCH, 2021, 7
[27] COMPARATIVE ANALYSIS OF HEPATOCELLULAR CARCINOMA RISK IN CHRONIC HEPATITIS B PATIENTS TREATED WITH TENOFOVIR ALAFENAMIDE ( TAF), TENOFOVIR DISOPROXIL FUMARATE ( TDF), AND ENTECAVIR ( ETV): A SYSTEMATIC REVIEW AND META- ANALYSIS WITH GRADE ASSESSMENT
Polpichai, Natchaya
Saowapa, Sakditad
Jaroenlapnopparat, Aunchalee
Wattanachayakul, Phuuwadith
Danpanichkul, Pojsakorn
Trongtorsak, Angkawipa
Sripongpun, Pimsiri Sripongpun
Chamroonkul, Naichaya
Tangkijvanich, Pisit
Liangpunsakul, Suthat
Piratvisuth, Teerha
Kaewdech, Apichat
HEPATOLOGY, 2024, 80 : S191 - S193
[28] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Ha, Yeonjung
Chon, Young Eun
Kim, Mi Na
Lee, Joo Ho
Hwang, Seong Gyu
SCIENTIFIC REPORTS, 2020, 10 (01)
[29] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Yeonjung Ha
Young Eun Chon
Mi Na Kim
Joo Ho Lee
Seong Gyu Hwang
Scientific Reports, 10
[30] An entecavir (ETV) and tenofovir (TDF) real world study - A retrospective review of long term entecavir and tenofovir therapy in chronic hepatitis B in Australia
Van Leest, R. L.
Ratnam, D. T.
Kronborg, I.
Lubel, J.
Roberts, S.
Nicholl, A.
Bell, S.
Gow P, P.
Dev, A. T.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 163 - 164

← 1 2 3 4 5 →